Skip to main content
Top
Published in: Medical Microbiology and Immunology 1/2023

03-12-2022 | Pneumonia | Original Investigation

Acinetobacter baumannii reinforces the pathogenesis by promoting IL-17 production in a mouse pneumonia model

Authors: Yangyang Zhou, Chuanying Xiang, Ning Wang, Xiaomin Zhang, Yu Xie, Hong Yang, Gang Guo, Kaiyun Liu, Yan Li, Yun Shi

Published in: Medical Microbiology and Immunology | Issue 1/2023

Login to get access

Abstract

Interleukin-17 (IL-17) is involved in host defense against bacterial infection. Little is known about the role of IL-17 in A. baumannii-infected pneumonia. Our objective was to investigate the role of IL-17 in pulmonary A. baumannii infection in a mouse model. We infected C57BL/6 mice intra-tracheally (i.t.) with A. baumannii to establish pneumonia model and found A. baumannii infection elevated IL-17 expression in lungs. IL-17-deficient (Il17−/−) mice were resistant to pulmonary A. baumannii infection, showing improved mice survival, reduced bacteria burdens, and alleviated lung inflammation. Further, treatment of A. baumannii-infected Il17−/− mice with IL-17 exacerbated the severity of pneumonia. These data suggest a pathogenic role of IL-17 in pulmonary A. baumannii infection. Further, the infiltration and phagocytic function of neutrophils in broncho-alveolar lavage fluid were detected by flow cytometry. The results showed that Il17−/− mice had increased neutrophil infiltration and enhanced phagocytosis in neutrophils at the early time of infection. Treatment of mice with IL-17 suppressed phagocytic function of neutrophils. All data suggest that IL-17 promotes susceptibility of mice to pulmonary A. baumannii infection by suppressing neutrophil phagocytosis at early time of infection. Targeting IL-17 might be a potential therapeutic strategy in controlling the outcome of A. baumannii pneumonia.
Appendix
Available only for authorised users
Literature
1.
go back to reference McConnell M, Actis L, Pachón J (2013) Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev 37(2):130–155CrossRefPubMed McConnell M, Actis L, Pachón J (2013) Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev 37(2):130–155CrossRefPubMed
2.
go back to reference Gallagher P, Baker S (2020) Developing new therapeutic approaches for treating infections caused by multi-drug resistant Acinetobacter baumannii: Acinetobacter baumannii therapeutics. J Infect 81(6):857–861CrossRefPubMed Gallagher P, Baker S (2020) Developing new therapeutic approaches for treating infections caused by multi-drug resistant Acinetobacter baumannii: Acinetobacter baumannii therapeutics. J Infect 81(6):857–861CrossRefPubMed
4.
go back to reference Mohd Sazlly Lim S, Zainal Abidin A, Liew SM, Roberts JA, Sime FB (2019)The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis. J Infect 79(6): 593–600 Mohd Sazlly Lim S, Zainal Abidin A, Liew SM, Roberts JA, Sime FB (2019)The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis. J Infect 79(6): 593–600
6.
go back to reference Kelly M, Kolls J, Happel K et al (2005) Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 73(1):617–621CrossRefPubMedPubMedCentral Kelly M, Kolls J, Happel K et al (2005) Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 73(1):617–621CrossRefPubMedPubMedCentral
7.
go back to reference Ye P, Rodriguez F, Kanaly S et al (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194(4):519–527CrossRefPubMedPubMedCentral Ye P, Rodriguez F, Kanaly S et al (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194(4):519–527CrossRefPubMedPubMedCentral
8.
go back to reference Chen K, Eddens T, Trevejo-Nunez G, et al (2016) IL-17 receptor signaling in the lung epithelium is required for mucosal chemokine gradients and pulmonary host defense against. Cell Host Microbe 20(5): 596–605 Chen K, Eddens T, Trevejo-Nunez G, et al (2016) IL-17 receptor signaling in the lung epithelium is required for mucosal chemokine gradients and pulmonary host defense against. Cell Host Microbe 20(5): 596–605
9.
go back to reference Bayes H, Ritchie N, Evans T (2016) Interleukin-17 is required for control of chronic lung infection caused by Pseudomonas aeruginosa. Infect Immun 84(12):3507–3516CrossRefPubMedPubMedCentral Bayes H, Ritchie N, Evans T (2016) Interleukin-17 is required for control of chronic lung infection caused by Pseudomonas aeruginosa. Infect Immun 84(12):3507–3516CrossRefPubMedPubMedCentral
10.
go back to reference Murakami T, Hatano S, Yamada H, Iwakura Y, Yoshikai Y (2016) Two types of interleukin 17A-producing γδ T cells in protection against pulmonary infection with Klebsiella pneumoniae. J Infect Dis 214(11):1752–1761CrossRefPubMed Murakami T, Hatano S, Yamada H, Iwakura Y, Yoshikai Y (2016) Two types of interleukin 17A-producing γδ T cells in protection against pulmonary infection with Klebsiella pneumoniae. J Infect Dis 214(11):1752–1761CrossRefPubMed
11.
go back to reference Way EE, Chen K, Kolls JK (2013) Dysregulation in lung immunity: The protective and pathologic Th17 response in infection. Eur J Immunol 43(12):3116–3124CrossRefPubMedPubMedCentral Way EE, Chen K, Kolls JK (2013) Dysregulation in lung immunity: The protective and pathologic Th17 response in infection. Eur J Immunol 43(12):3116–3124CrossRefPubMedPubMedCentral
12.
go back to reference Wonnenberg B, Jungnickel C, Honecker A, et al (2016) IL-17A attracts inflammatory cells in murine lung infection with P. aeruginosa. Innate Immunity 22(8): 620–625 Wonnenberg B, Jungnickel C, Honecker A, et al (2016) IL-17A attracts inflammatory cells in murine lung infection with P. aeruginosa. Innate Immunity 22(8): 620–625
13.
go back to reference Murdock BJ, Falkowski NR, Shreiner AB et al (2012) Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia. Infect Immun 80(4):1424–1436CrossRefPubMedPubMedCentral Murdock BJ, Falkowski NR, Shreiner AB et al (2012) Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia. Infect Immun 80(4):1424–1436CrossRefPubMedPubMedCentral
14.
go back to reference Shi Y, Liu XF, Zhuang Y et al (2010) Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol 184(9):5121–5129CrossRefPubMed Shi Y, Liu XF, Zhuang Y et al (2010) Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol 184(9):5121–5129CrossRefPubMed
16.
go back to reference Li C, Yang P, Sun Y et al (2012) IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus. Cell Res 22(3):528–538CrossRefPubMed Li C, Yang P, Sun Y et al (2012) IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus. Cell Res 22(3):528–538CrossRefPubMed
17.
go back to reference Song HW, Yang C, Liu W, Liu XW, Liu Z, Gao F (2017) Interleukin-17A plays the same role on mice acute lung injury respectively induced by lipopolysaccharide and paraquat. Inflammation 40(5):1509–1519CrossRefPubMed Song HW, Yang C, Liu W, Liu XW, Liu Z, Gao F (2017) Interleukin-17A plays the same role on mice acute lung injury respectively induced by lipopolysaccharide and paraquat. Inflammation 40(5):1509–1519CrossRefPubMed
18.
go back to reference Muir R, Osbourn M, Dubois A et al (2016) Innate lymphoid cells are the predominant source of IL-17A during the early pathogenesis of acute respiratory distress syndrome. Am J Respir Crit Care Med 193(4):407–416CrossRefPubMed Muir R, Osbourn M, Dubois A et al (2016) Innate lymphoid cells are the predominant source of IL-17A during the early pathogenesis of acute respiratory distress syndrome. Am J Respir Crit Care Med 193(4):407–416CrossRefPubMed
19.
go back to reference Liu M, Lu B, Fan H et al (2021) Heightened local Th17 cell inflammation is associated with severe community-acquired pneumonia in children under the age of 1 year. Mediators Inflamm 2021:9955168CrossRefPubMedPubMedCentral Liu M, Lu B, Fan H et al (2021) Heightened local Th17 cell inflammation is associated with severe community-acquired pneumonia in children under the age of 1 year. Mediators Inflamm 2021:9955168CrossRefPubMedPubMedCentral
20.
go back to reference Mikacenic C, Hansen EE, Radella F, Gharib SA, Stapleton RD, Wurfel MM (2016) Interleukin-17A is associated With alveolar inflammation and poor outcomes in acute respiratory distress syndrome. Crit Care Med 44(3):496–502CrossRefPubMedPubMedCentral Mikacenic C, Hansen EE, Radella F, Gharib SA, Stapleton RD, Wurfel MM (2016) Interleukin-17A is associated With alveolar inflammation and poor outcomes in acute respiratory distress syndrome. Crit Care Med 44(3):496–502CrossRefPubMedPubMedCentral
21.
go back to reference Li TJ, Zhao LL, Qiu J, Zhang HY, Bai GX, Chen L (2017) Interleukin-17 antagonist attenuates lung inflammation through inhibition of the ERK1/2 and NF-kappaB pathway in LPS-induced acute lung injury. Mol Med Rep 16(2):2225–2232CrossRefPubMed Li TJ, Zhao LL, Qiu J, Zhang HY, Bai GX, Chen L (2017) Interleukin-17 antagonist attenuates lung inflammation through inhibition of the ERK1/2 and NF-kappaB pathway in LPS-induced acute lung injury. Mol Med Rep 16(2):2225–2232CrossRefPubMed
22.
go back to reference Breslow J, Meissler J, Hartzell R et al (2011) Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance. Infect Immun 79(8):3317–3327CrossRefPubMedPubMedCentral Breslow J, Meissler J, Hartzell R et al (2011) Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance. Infect Immun 79(8):3317–3327CrossRefPubMedPubMedCentral
23.
go back to reference Zeng X, Gu H, Peng L et al (2020) Transcriptome profiling of lung innate immune responses potentially associated with the pathogenesis of Acinetobacter baumannii acute lethal pneumonia. Front Immunol 11:708CrossRefPubMedPubMedCentral Zeng X, Gu H, Peng L et al (2020) Transcriptome profiling of lung innate immune responses potentially associated with the pathogenesis of Acinetobacter baumannii acute lethal pneumonia. Front Immunol 11:708CrossRefPubMedPubMedCentral
24.
go back to reference Zeng X, Gu H, Peng L et al (2020) Acinetobacter baumannii transcriptome profiling of lung innate immune responses potentially associated with the pathogenesis of acute lethal pneumonia. Front Immunol 11:708CrossRefPubMedPubMedCentral Zeng X, Gu H, Peng L et al (2020) Acinetobacter baumannii transcriptome profiling of lung innate immune responses potentially associated with the pathogenesis of acute lethal pneumonia. Front Immunol 11:708CrossRefPubMedPubMedCentral
25.
go back to reference Kuleshov MV, Jones MR, Rouillard AD et al (2016) Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44(W1):W90–W97CrossRefPubMedPubMedCentral Kuleshov MV, Jones MR, Rouillard AD et al (2016) Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44(W1):W90–W97CrossRefPubMedPubMedCentral
26.
go back to reference Harris G, Kuo Lee R, Lam CK et al (2013) A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents Chemother 57(8):3601–3613CrossRefPubMedPubMedCentral Harris G, Kuo Lee R, Lam CK et al (2013) A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents Chemother 57(8):3601–3613CrossRefPubMedPubMedCentral
27.
go back to reference Rayamajhi M, Redente EF, Condon TV, Gonzalez-Juarrero M, Riches DW, Lenz LL (2011) Non-surgical intratracheal instillation of mice with analysis of lungs and lung draining lymph nodes by flow cytometry. J Vis Exp 2(51):2702 Rayamajhi M, Redente EF, Condon TV, Gonzalez-Juarrero M, Riches DW, Lenz LL (2011) Non-surgical intratracheal instillation of mice with analysis of lungs and lung draining lymph nodes by flow cytometry. J Vis Exp 2(51):2702
29.
go back to reference Lin L, Tan B, Pantapalangkoor P et al (2013) Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes. Vaccine 31(2):313–318CrossRefPubMed Lin L, Tan B, Pantapalangkoor P et al (2013) Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes. Vaccine 31(2):313–318CrossRefPubMed
30.
go back to reference van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, Chen W (2007) Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect Immun 75(12):5597–5608CrossRefPubMedPubMedCentral van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, Chen W (2007) Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect Immun 75(12):5597–5608CrossRefPubMedPubMedCentral
31.
go back to reference Qiu H, Li Z, KuoLee R, et al (2016) Host resistance to intranasal Acinetobacter baumannii reinfection in mice. Pathog Dis 74(5) Qiu H, Li Z, KuoLee R, et al (2016) Host resistance to intranasal Acinetobacter baumannii reinfection in mice. Pathog Dis 74(5)
32.
go back to reference Hsu D, Taylor P, Fletcher D et al (2016) Interleukin-17 pathophysiology and therapeutic intervention in cystic fibrosis lung infection and inflammation. Infect Immun 84(9):2410–2421CrossRefPubMedPubMedCentral Hsu D, Taylor P, Fletcher D et al (2016) Interleukin-17 pathophysiology and therapeutic intervention in cystic fibrosis lung infection and inflammation. Infect Immun 84(9):2410–2421CrossRefPubMedPubMedCentral
33.
go back to reference Li J, Zhang K, Fan W et al (2019) Transcriptome profiling reveals differential effect of interleukin-17A upon influenza virus infection in human cells. Front Microbiol 10:2344CrossRefPubMedPubMedCentral Li J, Zhang K, Fan W et al (2019) Transcriptome profiling reveals differential effect of interleukin-17A upon influenza virus infection in human cells. Front Microbiol 10:2344CrossRefPubMedPubMedCentral
34.
go back to reference Tiringer K, Treis A, Fucik P et al (2013) A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 187(6):621–629CrossRefPubMed Tiringer K, Treis A, Fucik P et al (2013) A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 187(6):621–629CrossRefPubMed
35.
go back to reference Li Q, Gu Y, Tu Q, Wang K, Gu X, Ren T (2016) Blockade of interleukin-17 restrains the development of acute lung injury. Scand J Immunol 83(3):203–211CrossRefPubMed Li Q, Gu Y, Tu Q, Wang K, Gu X, Ren T (2016) Blockade of interleukin-17 restrains the development of acute lung injury. Scand J Immunol 83(3):203–211CrossRefPubMed
36.
go back to reference Yan Z, Xiaoyu Z, Zhixin S et al (2016) Rapamycin attenuates acute lung injury induced by LPS through inhibition of Th17 cell proliferation in mice. Sci Rep 6:20156CrossRefPubMedPubMedCentral Yan Z, Xiaoyu Z, Zhixin S et al (2016) Rapamycin attenuates acute lung injury induced by LPS through inhibition of Th17 cell proliferation in mice. Sci Rep 6:20156CrossRefPubMedPubMedCentral
37.
go back to reference Ritchie ND, Ritchie R, Bayes HK, Mitchell TJ, Evans TJ (2018) IL-17 can be protective or deleterious in murine pneumococcal pneumonia. PLoS Pathog 14(5):e1007099CrossRefPubMedPubMedCentral Ritchie ND, Ritchie R, Bayes HK, Mitchell TJ, Evans TJ (2018) IL-17 can be protective or deleterious in murine pneumococcal pneumonia. PLoS Pathog 14(5):e1007099CrossRefPubMedPubMedCentral
38.
39.
go back to reference Wolf L, Sapich S, Honecker A et al (2016) IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol 311(5):L1015–L1022CrossRefPubMed Wolf L, Sapich S, Honecker A et al (2016) IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol 311(5):L1015–L1022CrossRefPubMed
40.
go back to reference Me R, Gao N, Dai C, Yu FX (2020) IL-17 Promotes Pseudomonas aeruginosa keratitis in C57BL/6 mouse corneas. J Immunol 204(1):169–179CrossRefPubMed Me R, Gao N, Dai C, Yu FX (2020) IL-17 Promotes Pseudomonas aeruginosa keratitis in C57BL/6 mouse corneas. J Immunol 204(1):169–179CrossRefPubMed
41.
go back to reference Liu J, Qu H, Li Q, Ye L, Ma G, Wan H (2013) The responses of gammadelta T-cells against acute Pseudomonas aeruginosa pulmonary infection in mice via interleukin-17. Pathog Dis 68(2):44–51CrossRefPubMed Liu J, Qu H, Li Q, Ye L, Ma G, Wan H (2013) The responses of gammadelta T-cells against acute Pseudomonas aeruginosa pulmonary infection in mice via interleukin-17. Pathog Dis 68(2):44–51CrossRefPubMed
42.
go back to reference Dubin PJ, Martz A, Eisenstatt JR, Fox MD, Logar A, Kolls JK (2012) Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection. Infect Immun 80(1):398–409CrossRefPubMedPubMedCentral Dubin PJ, Martz A, Eisenstatt JR, Fox MD, Logar A, Kolls JK (2012) Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection. Infect Immun 80(1):398–409CrossRefPubMedPubMedCentral
43.
go back to reference Burn GL, Foti A, Marsman G, Patel DF, Zychlinsky A (2021) The Neutrophil. Immunity 54(7):1377–1391CrossRefPubMed Burn GL, Foti A, Marsman G, Patel DF, Zychlinsky A (2021) The Neutrophil. Immunity 54(7):1377–1391CrossRefPubMed
44.
go back to reference Hesselink L, Spijkerman R, van Wessem KJP et al (2019) Neutrophil heterogeneity and its role in infectious complications after severe trauma. World journal of emergency surgery : WJES 14:24CrossRefPubMedPubMedCentral Hesselink L, Spijkerman R, van Wessem KJP et al (2019) Neutrophil heterogeneity and its role in infectious complications after severe trauma. World journal of emergency surgery : WJES 14:24CrossRefPubMedPubMedCentral
Metadata
Title
Acinetobacter baumannii reinforces the pathogenesis by promoting IL-17 production in a mouse pneumonia model
Authors
Yangyang Zhou
Chuanying Xiang
Ning Wang
Xiaomin Zhang
Yu Xie
Hong Yang
Gang Guo
Kaiyun Liu
Yan Li
Yun Shi
Publication date
03-12-2022
Publisher
Springer Berlin Heidelberg
Keyword
Pneumonia
Published in
Medical Microbiology and Immunology / Issue 1/2023
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-022-00757-2

Other articles of this Issue 1/2023

Medical Microbiology and Immunology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.